SLK Kliniken Heilbronn GmbH
1 clinical trials · Sponsor
◉ Watch SLK Kliniken Heilbronn GmbH
| Record | Firm | Date |
|---|---|---|
| IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients (NCT05641545) | SLK Kliniken Heilbronn GmbH | 2022-10-17 |
Track SLK Kliniken Heilbronn GmbH automatically
Every clearance here is in the API, with alerts when new ones post.